7275 related articles for article (PubMed ID: 11001503)
1. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
[TBL] [Abstract][Full Text] [Related]
2. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
[TBL] [Abstract][Full Text] [Related]
3. 131I-rituximab: relationship between immunoreactivity and specific activity.
Schaffland AO; Buchegger F; Kosinski M; Antonescu C; Paschoud C; Grannavel C; Pellikka R; Delaloye AB
J Nucl Med; 2004 Oct; 45(10):1784-90. PubMed ID: 15471849
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autoradiolysis of radiolabeled monoclonal antibodies by cryopreservation.
Wahl RL; Wissing J; del Rosario R; Zasadny KR
J Nucl Med; 1990 Jan; 31(1):84-9. PubMed ID: 2295945
[TBL] [Abstract][Full Text] [Related]
6. Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinations.
Mujoo K; Rosenblum MG; Murray JL
Cancer Res; 1991 Jun; 51(11):2768-72. PubMed ID: 2032216
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
[TBL] [Abstract][Full Text] [Related]
8. Radiochemical purity and in vitro stability of commercial hippurans.
Hammermaier A; Reich E; Bögl W
J Nucl Med; 1986 Jun; 27(6):850-4. PubMed ID: 3712098
[TBL] [Abstract][Full Text] [Related]
9. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
[TBL] [Abstract][Full Text] [Related]
10. Preparation and storage of single-dose portions of exametazime: effects on radiochemical purity after labeling.
Cheng KT; Spicer KM; Deshpande RV
Am J Hosp Pharm; 1992 Aug; 49(8):1950-4. PubMed ID: 1332470
[TBL] [Abstract][Full Text] [Related]
11. Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
Stein R; Govindan SV; Mattes MJ; Shih LB; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3079s-3087s. PubMed ID: 10541347
[TBL] [Abstract][Full Text] [Related]
12. Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines.
Matzku S; Bröcker EB; Brüggen J; Dippold WG; Tilgen W
Cancer Res; 1986 Aug; 46(8):3848-54. PubMed ID: 3731060
[TBL] [Abstract][Full Text] [Related]
13. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
14. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
[TBL] [Abstract][Full Text] [Related]
15. Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.
Yu MH; Roffler SR; Hwang WS; Tung E; Chen WL; Yeh MY
Gynecol Oncol; 1992 Oct; 47(1):93-101. PubMed ID: 1427409
[TBL] [Abstract][Full Text] [Related]
16. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
17. The fate of antibodies bound to the surface of tumor cells in vitro.
Kyriakos RJ; Shih LB; Ong GL; Patel K; Goldenberg DM; Mattes MJ
Cancer Res; 1992 Feb; 52(4):835-42. PubMed ID: 1737345
[TBL] [Abstract][Full Text] [Related]
18. New monoclonal antibody against human cervical carcinoma with diagnostic and therapeutic potential.
Roffler SR; Yu MH; Chen MR; Chen SC; Hsu CT; Yeh MY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):19-29. PubMed ID: 1935367
[TBL] [Abstract][Full Text] [Related]
19. Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI).
Orlova A; Bruskin A; Sivaev I; Sjöberg S; Lundqvist H; Tolmachev V
Anticancer Res; 2006; 26(2A):1217-23. PubMed ID: 16619527
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
